Active surveillance for low-risk prostate cancer: an update.
about
Potential Utility of Novel Biomarkers in Active Surveillance of Low-Risk Prostate CancerUsing routinely collected data to stratify prostate cancer patients into phases of care in the United Kingdom: implications for resource allocation and the cancer survivorship programme.Assessment of Prostate Cancer Aggressiveness by Use of the Combination of Quantitative DWI and Dynamic Contrast-Enhanced MRI.Expression changes in the stroma of prostate cancer predict subsequent relapseOur results of active surveillance for localized prostate cancer patients.Tissue biomarkers for prostate cancer radiation therapy.Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohortMany young men with prostate-specific antigen (PSA) screen-detected prostate cancers may be candidates for active surveillance.Serum prostate-specific antigen (PSA) concentration is positively associated with rate of disease reclassification on subsequent active surveillance prostate biopsy in men with low PSA density.Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma.Active surveillance for low-risk prostate cancer: knowledge, acceptance and practice among urologists.Individualized prostate-specific antigen threshold values to avoid overdiagnosis of prostate cancer and reduce unnecessary biopsy in elderly men.PI-RADS version 2 for prediction of pathological downgrading after radical prostatectomy: a preliminary study in patients with biopsy-proven Gleason Score 7 (3+4) prostate cancer.Updated clinical results of active surveillance of very-low-risk prostate cancer in Korean men: 8 years of follow-up.The accuracy of prostate cancer localization diagnosed on transrectal ultrasound-guided biopsy compared to 3-dimensional transperineal approach.Genetic variants associated with predisposition to prostate cancer and potential clinical implications.A single centre experience of active surveillance as management strategy for low-risk prostate cancer in Ireland.Optimizing active surveillance strategies to balance the competing goals of early detection of grade progression and minimizing harm from biopsies.Anxiety and health-related quality of life (HRQL) in patients undergoing active surveillance of prostate cancer in an Australian centre.Prostate focused ultrasound focal therapy--imaging for the future.Looking forward, looking back-10 years in urology.The Use of Biomarkers in Prostate Cancer Screening and Treatment.Should inclusion criteria for active surveillance for low-risk prostate cancer be more stringent? From an interim analysis of PRIAS-JAPAN.Transperineal versus transrectal prostate biopsy for predicting the final laterality of prostate cancer: are they reliable enough to select patients for focal therapy? Results from a multicenter international study.
P2860
Q26784517-2665E12A-7D57-42FD-972B-51519AA95A73Q30912685-C0575B84-5373-469F-8786-AAADBE99EC70Q33821885-F8B3CB56-FDE1-4C42-B79B-2AA5012A970BQ34368873-457DFBD4-E5FD-4D18-86E6-06182229117FQ35993855-9EACB77D-5AA1-4363-BE6A-2018535C3AD1Q36141341-B5797215-F93B-4C59-AE50-CB1A617C4007Q36787957-45E014F9-F3FB-46AB-9D71-AA4A4798CF23Q36798276-6213D13E-1258-488B-BD57-A7C65C6FFB7EQ37689245-15B608AA-EBD8-4271-B0CE-5EC7FD7D357FQ39264728-96F1A016-A104-47ED-8A71-B568BBF3CC7AQ39679009-7F24D2E0-19B5-4671-AA36-61B08B4181B9Q40207835-3603678A-C17A-4509-8DBA-048194CA3360Q40928990-A9800B22-72C0-40BD-AF24-C76A01047B2BQ41829711-CC2DCF00-AAE8-422C-A98A-71525D744DAAQ41871289-F7412E8C-9650-4A04-A631-7FC989DD6571Q43415543-DED4BAFF-EFA9-4CAA-8121-BBE36891C07AQ45276161-FDDB6401-9309-4B02-B09F-635D24F2B28EQ47608517-F6597A9A-9B2D-4CF4-8B2F-DE5DBA2033CDQ47866580-67B82F93-2D57-45FA-BC6C-AEA34B3CEA0DQ50244924-31114080-6FE0-4BA4-A17C-03179DBF6A00Q50626554-45EA4406-5E9F-439E-B48C-40F66359E5E6Q52689045-A4DD59C0-F69B-4D66-B860-4224E54FAFC9Q53080988-B1C87D75-FDE6-4C38-BF29-5B14EDF13E5DQ53093296-F3C6E4C4-F849-4B2D-BA9E-B17F41DF2F9A
P2860
Active surveillance for low-risk prostate cancer: an update.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Active surveillance for low-risk prostate cancer: an update.
@en
Active surveillance for low-risk prostate cancer: an update.
@nl
type
label
Active surveillance for low-risk prostate cancer: an update.
@en
Active surveillance for low-risk prostate cancer: an update.
@nl
prefLabel
Active surveillance for low-risk prostate cancer: an update.
@en
Active surveillance for low-risk prostate cancer: an update.
@nl
P2860
P356
P1476
Active surveillance for low-risk prostate cancer: an update.
@en
P2860
P2888
P304
P356
10.1038/NRUROL.2011.50
P407
P577
2011-04-26T00:00:00Z